Effect of Interventions on the Progression of Knee Osteoarthritis
Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
There has been intensive search for a substance that can have disease-modifying activity for
osteoarthritis. A number of medications have been reported to be of benefit on slowing
progression of knee OA. This trial will be the first head to head comparison of these
medications.
Patients aged between age 40 to 65 will be enrolled. Patients will be assessed clinically
using two scoring systems, the WOMAC index for knee arthritis and the SF 36 for overall
physical and mental health. The knee X rays will be assessed on Kellgren and Lawrence grading
and will also be measured for joint space narrowing at follow up. The response to arthritis
medications on slowing down cartilage loss will be measured biochemically with COMP levels.